Welcome to the Emerging Pathogens & Infectious Diseases Consortium

Welcome to EPIC – the Emerging Pathogens and Infectious Diseases Consortium.

EPIC brings together researchers, clinicians, and institutions across the University of Toronto and its hospital partners to advance infectious disease research and build lasting resilience against emerging threats.

This work builds on a long legacy: EPIC partners have played an integral role in infectious disease research for a century, from work that helped control diphtheria and eradicate smallpox, to today’s front-line research in antimicrobial resistance and infection control. Our collective response to COVID-19, highly pathogenic avian influenza, and mpox makes clear there’s never been a more important time to advance that work, from emerging pathogens and antimicrobial resistance to health inequities and public trust.

Building on this momentum, EPIC marshals the advanced research infrastructure and world-renowned research and training expertise of our EPIC partners to deliver an integrated, innovative response to the infectious disease challenges facing communities today and in the future.

Seven EPIC research clusters

radar

Emerging Pathogens

Detecting and responding to new and re-emerging threats before they spread.

Antimicrobial Resistance

Protecting the effectiveness of the medicines we depend on.

Icon on Miscroscope

Sepsis & Acute Respiratory Distress

Improving recognition and treatment when every minute counts.

Icon of Network Connections

Chronic Infections

Addressing the long-term burden of infections that don’t resolve.

Health Inequities

Ensuring infectious disease research and response reach everyone, equitably.

Health Systems Resilience

Building health systems that bend, not break, under infectious threats.

Icon on Miscroscope

Mis/Disinformation & Public Trust

Strengthening public trust through clear, credible information.

EPIC News

Upcoming Events